Core Viewpoint - BofA has lowered the price target for Braskem (BAK) to $3.30 from $3.70, maintaining a Neutral rating due to recent legislative changes in Brazil that negatively impact the company's expected benefits [1] Group 1: Price Target Adjustment - BofA reduced the price target for Braskem from $3.70 to $3.30 [1] - The firm maintains a Neutral rating on Braskem shares following the price target adjustment [1] Group 2: Legislative Impact - Brazilian President sanctioned Draft Bill (PL) 892/2025, which establishes the PRESIQ benefit and the REIQ's rate schedule [1] - The proposed increase in REIQ for 2026 was vetoed, which was previously incorporated into the firm's expectations [1] - The analyst views the news as negative for Braskem, as it alters anticipated benefits for the company [1]